JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1667.5
  • -2.5-0.15%
20min DelayNot Open Nov 14 15:30 JST
3.02TMarket Cap176.08P/E (Static)

Astellas Pharma Key Stats

EPS
According to the latest financial report of Astellas Pharma, the latest earnings per share (TTM) for the company is 20.94. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

Loading...

FCF
Interested in knowing about Astellas Pharma's free cash flow? The latest report shows it as -26.75B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Astellas Pharma shows that the company's current ratio is 1.10, indicating healthy liquidity.

Currency: JPY

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Astellas Pharma, the quick ratio is 0.81, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

Loading...

ROE
Want to learn more about the financial health of Astellas Pharma? The latest ROE figure is -2.15%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Astellas Pharma, the total asset return on investment (ROA) is -0.96%.

Currency: JPY

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Astellas Pharma's latest financial report to see how their gross margin is doing - currently at 80.74%.

Currency: JPY

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Astellas Pharma, the net profit margin is 7.95%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Loading...

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data